Healthcare Industry News: Kyphon
News Release - September 27, 2017
Conventus Orthopaedics Appoints Richard Mott to its Board of DirectorsMINNEAPOLIS, Sept. 27, 2017 -- (Healthcare Sales & Marketing Network) -- Conventus Orthopaedics, a medical device company revolutionizing fracture repair surgery, today announced that Richard Mott has been appointed to its Board of Directors, effective immediately.
"We are pleased to welcome Rich to our Board and look forward to benefiting from his extensive track record of success and leadership in the orthopaedic industry," said Matthew Jewett, President and Chief Executive Officer of Conventus. "His experience in building and scaling high potential medical device platforms will be invaluable as we continue to introduce additional innovative Cage technology solutions and build a solid foundation for future commercial growth."
"I am excited to join an organization dedicated to revolutionizing fracture repair surgery and improving outcomes for patients," said Richard Mott. "It is an especially exciting time to be a part of Conventus as the company prepares to launch an enhanced proximal humerus (PH) system and as compelling data on 125 proximal humerus patients will be presented at the Orthopaedic Trauma Association (OTA) conference in Vancouver next month."
About Conventus Orthopaedics, Inc.
Conventus Orthopaedics, Inc. was founded by a team of medical device professionals and physicians with the sole purpose of improving patient care by creating a 3-dimensional platform technology with less invasive solutions to a broad range of challenging periarticular fractures. Taking its name from the Latin word for coming together or union, Conventus Orthopaedics is focused on creating less invasive solutions to fractures in and around the joints. The company is dedicated to working with surgeons to improve healing and enable their patients' return to normal activities.
Source: Conventus Orthopaedics
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.